Connect with us
In 2015, Nostoc closed the first round of investment worth $296,000 (€250,000) through the Social Exchange's participatory investment platform. Since then, the company has been growing...
The clinical trial, led by the Catholic University, together with other universities and the Sinovac Biotech laboratory, already has funding from the public sector, the Confederation...
The Swiss pharmaceutical company Roche will supply reagents and consumables and will provide the necessary equipment to carry out analytical serological and biochemical determinations. The BST...
Faes Farma, Pharma Mar, Reig Jofre and Rovi improved their earnings in the first six months of the year. Grifols and Almirall were the two pharma...
Nantes-based biotech company Xenothera is developing Xav-19, a promising antibody for the treatment of COVID-19. Initially announced for the end of June, the start of the...
In March, BioNTech's share price, after rallying to $105, plummeted in two stages to initially $43.66 and then, after an interim recovery to $64.45, to $37....
Almirall cuts its profits as a result of the coronavirus crisis. The Spanish pharmaceutical company justifies this result by the negative impact on the area of...
Managed and owned by Bernard Tannoury, the Benta Pharma group has achieved sales of $77.5 million in 2019 and distributes its products in more than 40...
According to different studies, the 3D bioprinting market will reach a value of $1.65 billion in 2024. The Spanish company Regemat 3D will soon launch a...
Celyad Oncology has just had a clinical trial validated by the FDA, a major milestone in the development of Nasdaq-listed biotech company. On Tuesday, July 14th,...
 |
|
 |  |
 |
|